Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index

World Journal of Gastroenterology

Volumn 21, Issue 5, 2015, Pages 1650-1662

  Pang, Qing ^a   Zhang, Jing Yao ^a   Song, Si Dong ^a   Qu, Kai ^a   Xu, Xin Sen ^a   Liu, Su Shun ^a   Liu, Chang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Body mass index; Central obesity; General obesity; Nonalcoholic fatty liver disease; Waist circumference

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EFFECT SIZE; HUMAN; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; SENSITIVITY ANALYSIS; WAIST CIRCUMFERENCE; WAIST HIP RATIO; META ANALYSIS; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT;

BODY MASS INDEX; HUMANS; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84922566887     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i5.1650     Document Type: Article

References (85)

1. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-210 [PMID: 19014878 DOI: 10.1016/j.jhep.2008.10.010]
2. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905 [PMID: 15795412 DOI: 10.1503/cmaj.045232]
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
4. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56: 1384-1391 [PMID: 22326465 DOI: 10.1016/j.jhep.2011.10.027]
5. Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX, Zheng M. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013; 19: 3134-3142 [PMID: 23716995 DOI: 10.3748/wjg.v19.i20.3134]
6. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
7. Yasutake K, Kohjima M, Kotoh K, Nakashima M, Nakamuta M, Enjoji M. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 1756-1767 [PMID: 24587653 DOI: 10.3748/wjg.v20.i7.1756]
8. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013; 8: e53916 [PMID: 23349764 DOI: 10.1371/journal.pone.0053916]
9. Frank LK, Heraclides A, Danquah I, Bedu-Addo G, Mockenhaupt FP, Schulze MB. Measures of general and central obesity and risk of type 2 diabetes in a Ghanaian population. Trop Med Int Health 2013; 18: 141-151 [PMID: 23190041 DOI: 10.1111/tmi.12024]
10. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003; 4: 157-173 [PMID: 12916817]
11. Bruce KD, Byrne CD. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009; 85: 614-621 [PMID: 19892897 DOI: 10.1136/pgmj.2008.078014]
12. Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012; 27: 1555-1560 [PMID: 22741595 DOI: 10.1111/j.1440-1746.2012.07222.x]
13. Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2006; 64: 337-341 [PMID: 16487446 DOI: 10.1111/j.1365-2265.2006.02466.x]
14. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 2003; 98: 2771-2776 [PMID: 14687831 DOI: 10.1111/j.1572-0241.2003.08767.x]
15. Machado MV, Cortez-Pinto H. No need for a large belly to have NASH. J Hepatol 2011; 54: 1090-1093 [PMID: 21281684 DOI: 10.1016/j.jhep.2011.01.010]
16. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 2007; 22: 794-800 [PMID: 17498218 DOI: 10.1111/j.1440-1746.2007.04952.x]
17. Otgonsuren M, Stepanova M, Gerber L, Younossi ZM. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci 2013; 58: 1132-1140 [PMID: 23143735 DOI: 10.1007/s10620-012-2446-3]
18. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007; 133: 1814-1820 [PMID: 18054554 DOI: 10.1053/j.gastro.2007.08.077]
19. Guidorizzi de Siqueira AC, Cotrim HP, Rocha R, Carvalho FM, de Freitas LA, Barreto D, Gouveia L, Landeiro L. Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. Eur J Gastroenterol Hepatol 2005; 17: 837-841 [PMID: 16003133]
20. Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, Lee J, Kim DL, Choi KM, Baik SH, Choi DS, Kim SG. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008; 68: 555-560 [PMID: 17941908 DOI: 10.1111/j.1365-2265.2007.03072.x]
21. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med 2013; 16: 584-589 [PMID: 24093139]
22. Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006; 130: 2023-2030 [PMID: 16762625 DOI: 10.1053/j.gastro.2006.03.019]
23. Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China. J Hepatol 2013; 58: 557-563 [PMID: 23142063 DOI: 10.1016/j.jhep.2012.10.029]
24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012 [PMID: 10789670]
25. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309 [PMID: 1626547]
26. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578 [PMID: 18280327 DOI: 10.1016/s0140-6736(08)60269-x]
27. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006; 26: 856-863 [PMID: 16911469 DOI: 10.1111/j.1478-3231.2006.01311.x]
28. Park SK, Lee HJ, Lee DH, Lee SK, Chun BY, Kim SA, Lee HS, Son HK, Kim SH. [Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids]. J Prev Med Public Health 2008; 41: 39-44 [PMID: 18250604]
29. Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. Korean J Hepatol 2008; 14: 77-88 [PMID: 18367860 DOI: 10.3350/kjhep.2008.14.1.77]
30. Tsai CH, Li TC, Lin CC. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J 2008; 101: 900-905 [PMID: 18708987 DOI: 10.1097/SMJ.0b013e31817e8af9]
31. Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K. High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. J Gastroenterol 2009; 44: 313-321 [PMID: 19271113 DOI: 10.1007/s00535-009-0002-5]
32. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, Dhibar T, Bhattacharya B, Bhattacharya D, Manna B, Dhali GK, Santra A, Chowdhury A. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010; 51: 1593-1602 [PMID: 20222092 DOI: 10.1002/hep.23567]
33. Pinidiyapathirage MJ, Dassanayake AS, Rajindrajith S, Kalubowila U, Kato N, Wickremasinghe AR, de Silva HJ. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res Notes 2011; 4: 513 [PMID: 22115060 DOI: 10.1186/1756-0500-4-513]
34. Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J. Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract 2012; 2012: 362147 [PMID: 22701476 DOI: 10.1155/2012/362147]
35. Wengert S, Oeztuerk S, Haenle MM, Koenig W, Imhof A, Boehm BO, Wilhelm M, Mao R, Mason RA, Kratzer W. Association of proinsulin and hepatic steatosis in a random, population-based sample. Eur J Endocrinol 2013; 168: 195-202 [PMID: 23136404 DOI: 10.1530/eje-12-0605]
36. Yoon D, Lee SH, Park HS, Lee JH, Park JS, Cho KH, Kim SM. Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease. J Korean Med Sci 2005; 20: 421-426 [PMID: 15953863]
37. Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Diabetes Care 2007; 30: 2113-2118 [PMID: 17475935 DOI: 10.2337/dc07-0512]
38. Xu C, Xu L, Yu C, Miao M, Li Y. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf) 2011; 75: 240-246 [PMID: 21521285 DOI: 10.1111/j.1365-2265.2011.04016.x]
39. Sathiaraj E, Chutke M, Reddy MY, Pratap N, Rao PN, Reddy DN, Raghunath M. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. Eur J Clin Nutr 2011; 65: 533-537 [PMID: 21346716 DOI: 10.1038/ejcn.2011.3]
40. Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. J Dig Dis 2012; 13: 153-160 [PMID: 22356310 DOI: 10.1111/j.1751-2980.2011.00571.x]
41. Cheah WL, Lee PY, Chang CT, Mohamed HJ, Wong SL. Prevalence of ultrasound diagnosed nonalcoholic fatty liver disease among rural indigenous community of Sarawak and its association with biochemical and anthropometric measures. Southeast Asian J Trop Med Public Health 2013; 44: 309-317 [PMID: 23691641]
42. Foster T, Anania FA, Li D, Katz R, Budoff M. The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig Dis Sci 2013; 58: 2392-2398 [PMID: 23546700 DOI: 10.1007/s10620-013-2652-7]
43. Ying X, Jiang Y, Qian Y, Jiang Z, Song Z, Zhao C. Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults. Iran J Public Health 2012; 41: 45-49 [PMID: 23113121]
44. Hu X, Huang Y, Bao Z, Wang Y, Shi D, Liu F, Gao Z, Yu X. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 2012; 12: 123 [PMID: 22978800 DOI: 10.1186/1471-230x-12-123]
45. Sung KC, Kim BS, Cho YK, Park DI, Woo S, Kim S, Wild SH, Byrne CD. Predicting incident fatty liver using simple cardiometabolic risk factors at baseline. BMC Gastroenterol 2012; 12: 84 [PMID: 22770479 DOI: 10.1186/1471-230x-12-84]
46. Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, Kang HJ, Song W, Yeon JE, Baik SH, Choi DS, Choi KM. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int 2010; 30: 1189-1196 [PMID: 20602679 DOI: 10.1111/j.1478-3231.2010.02300.x]
47. Kim C, Harlow SD, Karvonen-Gutierrez CA, Randolph JF, Helmuth M, Kong S, Nan B, Carlos R. Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation. Diabet Med 2013; 30: 1433-1441 [PMID: 23659546 DOI: 10.1111/dme.12225]
48. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33 [PMID: 17081293 DOI: 10.1186/1471-230x-6-33]
49. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508-514 [PMID: 16006003 DOI: 10.1016/j.jhep.2005.02.042]
50. Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, Lee FY, Wu JC. Inverse association between hepatitis B virus infection and fatty liver disease: a largescale study in populations seeking for check-up. PLoS One 2013; 8: e72049 [PMID: 23991037 DOI: 10.1371/journal.pone.0072049]
51. Liu SH, Lazo M, Koteish A, Kao WH, Shih MH, Bonekamp S, Hernaez R, Clark JM. Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III. J Gastroenterol 2013; 48: 1151-1159 [PMID: 23188092 DOI: 10.1007/s00535-012-0715-8]
52. Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, Janssen HL. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012; 57: 1305-1311 [PMID: 22871499 DOI: 10.1016/j.jhep.2012.07.028]
53. Caballería L, Pera G, Auladell MA, Torán P, Muñoz L, Miranda D, Alumà A, Casas JD, Sánchez C, Gil D, Aubà J, Tibau A, Canut S, Bernad J, Aizpurua MM. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol 2010; 22: 24-32 [PMID: 19730384 DOI: 10.1097/MEG.0b013e32832fcdf0]
54. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009; 84: 84-91 [PMID: 19168251 DOI: 10.1016/j.diabres.2008.11.039]
55. Lai SW, Ng KC. Which anthropometric indices best predict metabolic disorders in Taiwan? South Med J 2004; 97: 578-582 [PMID: 15255425]
56. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007; 13: 6419-6424 [PMID: 18081233]
57. Inabe F, Takahashi E, Moriyama K, Negami M, Otsuka H. Risk assessment chart for predicting fatty liver in Japanese subjects. Tokai J Exp Clin Med 2012; 37: 94-101 [PMID: 23238900]
58. Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, Yeung DK, Yiu KK, Chu SH, Woo J, Chan FK, Chan HL. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-415 [PMID: 21846782 DOI: 10.1136/gutjnl-2011-300342]
59. Meier CR, Krähenbühl S, Schlienger RG, Jick H. Association between body mass index and liver disorders: an epidemiological study. J Hepatol 2002; 37: 741-747 [PMID: 12445413]
60. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012; 23: 843-852 [PMID: 21890910 DOI: 10.1093/annonc/mdr398]
61. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 1399-1412.e7 [PMID: 23707461 DOI: 10.1016/j.cgh.2013.05.009]
62. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-79 [PMID: 12512031 DOI: 10.1053/gast.2003.50004]
63. Papatheodoridis GV, Goulis J, Christodoulou D, Manolakopoulos S, Raptopoulou M, Andrioti E, Alexandropoulos N, Savvidou S, Papachristou A, Zervou E, Seferiadis K, Kousidou P, Vogiatzakis E, Tsianos E. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. Eur J Gastroenterol Hepatol 2007; 19: 281-287 [PMID: 17353691 DOI: 10.1097/MEG.0b013e328011438b]
64. Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N, Lobello R. Silent nonalcoholic fatty liver disease-a clinical-histological study. J Hepatol 2004; 41: 751-757 [PMID: 15519647 DOI: 10.1016/j.jhep.2004.07.010]
65. Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H. Difference and similarity between nonalcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res 2005; 29: 259S-263S [PMID: 16385233]
66. Hamano M, Kamada Y, Kiso S, Furuta K, Kizu T, Chatani N, Egawa M, Takemura T, Ezaki H, Yoshida Y, Watabe K, Hamasaki T, Umeda M, Furubayashi A, Kinoshita K, Kishida O, Fujimoto T, Yamada A, Tsukamoto Y, Tsutsui S, Takehara T, Hayashi N, Matsuzawa Y. Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction: Health check-up study of Japanese men. Hepatol Res 2013; 43: 238-248 [PMID: 22835062 DOI: 10.1111/j.1872-034X.2012.01066.x]
67. Gonzalez-Quintela A, Tomé S, Fernandez-Merino C, Rey J, Meijide L, Gude F. Synergistic effect of alcohol consumption and body mass on serum concentrations of cytokeratin-18. Alcohol Clin Exp Res 2011; 35: 2202-2208 [PMID: 21682752 DOI: 10.1111/j.1530-0277.2011.01570.x]
68. Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem? J Hepatol 2007; 46: 1133-1142 [PMID: 17445934 DOI: 10.1016/j.jhep.2007.03.003]
69. Lonardo A, Carani C, Carulli N, Loria P. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006; 44: 1196-1207 [PMID: 16618516 DOI: 10.1016/j.jhep.2006.03.005]
70. Ishibashi E, Eguchi Y, Eguchi T, Matsunobu A, Oza N, Nakashita S, Kitajima Y, Kuroki S, Ozaki I, Kawaguchi Y, Ide Y, Yasutake T, Iwakiri R, Mizuta T, Ono N, Fujimoto K. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol 2008; 23: 908-913 [PMID: 18373563 DOI: 10.1111/j.1440-1746.2008.05366.x]
71. Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20: 54-60 [PMID: 12533370]
72. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110 [PMID: 2227807]
73. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48 Suppl 1: S104-S112 [PMID: 18304679 DOI: 10.1016/j.jhep.2008.01.009]
74. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-2175 [PMID: 15505132 DOI: 10.1001/archinte.164.19.2169]
75. Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond) 2009; 6: 6 [PMID: 19291292 DOI: 10.1186/1476-9255-6-6]
76. Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol 2011; 17: 2801-2811 [PMID: 21734787 DOI: 10.3748/wjg.v17.i23.2801]
77. Schäffler A, Schölmerich J, Büchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 273-280 [PMID: 16265231 DOI: 10.1038/ncpgasthep0186]
78. Borst SE. The role of TNF-alpha in insulin resistance. Endocrine 2004; 23: 177-182 [PMID: 15146098 DOI: 10.1385/ENDO:23:2-3:177]
79. Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol 2008; 43: 811-822 [PMID: 19012034 DOI: 10.1007/s00535-008-2213-6]
80. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15: 6017-6022 [PMID: 20027672]
81. Chan DC, Watts GF, Gan SK, Ooi EM, Barrett PH. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010; 33: 1134-1139 [PMID: 20185740 DOI: 10.2337/dc09-1765]
82. Peng L, Wang J, Li F. Weight reduction for non-alcoholic fatty liver disease. Cochrane Database Syst Rev 2011; (6): CD003619 [PMID: 21678341 DOI: 10.1002/14651858.CD003619.pub3]
83. Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis 2008; 28: 407-426 [PMID: 18956297 DOI: 10.1055/s-0028-1091985]
84. Nair S. Nonalcoholic Fatty liver disease from the perspective of an internist. Ochsner J 2002; 4: 92-97 [PMID: 22822324]
85. Said A. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. World J Gastroenterol 2013; 19: 9146-9155 [PMID: 24409043 DOI: 10.3748/wjg.v19.i48.9146]